1. Implementing the Updated American Thyroid Association Guidelines and Recommendations for RAI-R DTC

2. Program Goals

3. Differentiated Thyroid Cancer

4. Treatment for RAI-R DTC

5. Guidelines

6. ATA Guidelines

7. Case 58-Year-Old Woman With Papillary Thyroid Carcinoma

8. Follow-Up Questions About the Case

9. Case (cont)

10. Case (cont)

11. Approaches

12. Case (cont)

13. Defining RAI-R Disease

14. Case (cont)

15. ATA Guidelines on Kinase Inhibitor Therapy

16. ATA Guidelines Factors Favoring Kinase Inhibitor Therapy

17. ATA Guidelines Factors Discouraging Kinase Inhibitor Therapy

18. Case (cont)

19. First-Line Treatment Options

20. Sorafenib DECISION Trial

21. Lenvatinib SELECT Trial

22. Case (cont)

23. ATA Guidelines Monitoring

24. Case Conclusion

25. Choosing Between Therapies

26. Second-Line Therapy Options

27. Abbreviations

28. Abbreviations (cont)